FLUCONAZOLE ( DrugBank: Fluconazole )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	4
225	先天性腎性尿崩症	1

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03476317 (ClinicalTrials.gov)	July 12, 2018	8/1/2018	Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's ...	An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refr ...	Crohn Disease	Drug: Vancomycin;Drug: Neomycin;Drug: Ciprofloxacin;Drug: Polyethylene Glycol 3350;Drug: Fluconazole ...	Children's Hospital of Philadelphia	University of Pennsylvania;National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	6 Years	N/A	All	10	Phase 2	United States
2	NCT02765256 (ClinicalTrials.gov)	August 2016	2/5/2016	Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease	Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease	Crohn's Disease	Drug: Fluconazole;Drug: Vancomycin;Drug: Neomycin;Drug: Ciprofloxacin;Drug: Polyethylene Glycol 3350 ...	University of Pennsylvania	Children's Hospital of Philadelphia;Crohn's and Colitis Foundation	Completed	18 Years	75 Years	All	8	Phase 2	United States
3	EUCTR2008-003167-39-BE (EUCTR)	17/09/2008	28/08/2008	Effet du fluconazolesur le taux d'anticorps anti-Saccharomyces cerevisiae (ASCSA) après résection ch ...	Effet du fluconazolesur le taux d'anticorps anti-Saccharomyces cerevisiae (ASCSA) après résection ch ...	Crohn' disease MedDRA version: 9.1;Level: LLT;Classification code 10011401;Term: Crohn's disease	Trade Name: diflucan INN or Proposed INN: FLUCONAZOLE	Cliniques Universitaires Saint Luc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60		Belgium
4	NCT02997059 (ClinicalTrials.gov)	July 2008	14/12/2016	Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease.	Effect of Fluconazoleon the Levels of Anti-Saccharomyces Cerevisiae Antibodies (ASCA) After Surgical ...	Crohn's Disease Aggravated	Drug: Fluconazole;Other: Placebo	University Hospital, Lille	Ministry of Health, France	Terminated	18 Years	N/A	Both	35	Phase 2	France

First Previous1Next Last

225. 先天性腎性尿崩症

臨床試験数 : 15 / 薬物数 : 48 - (DrugBank : 18) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 65

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-002204-38-DK (EUCTR)	24/11/2020	07/05/2020	Treatment of the genetic disease nephrogenic diabetes insipidus with the antifungal drug Fluconazole ...	Treatment of congenital nephrogenic diabetes insipidus with fluconazole, an antifungal medication	Nephrogenic diabetes insipidus MedDRA version: 21.0;Level: LLT;Classification code 10012600;Term: Di ...	INN or Proposed INN: Fluconazole Other descriptive name: FLUCONAZOLE	Claus Bistrup	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	10	Phase 2	Denmark

First Previous1Next Last

先頭へ